Corporate development in biotechnology in 2005

Alan Williams

DOI:https://doi.org/10.5912/jcb123

Abstract:

In 1998 the author produced two papers which argued that consolidation was a necessary activity for biotechnology companies to consider more. Three years later a further consideration of the subject was published. Corporate developments in biotechnology in the first decade of the 21st century are now considered.

Keywords:consolidation ,merger ,acquisition ,business model ,en ,